Year |
Citation |
Score |
2009 |
Bose SK, Gibson W, Giri S, Nath N, Donald CD. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor. The Prostate. 69: 1334-42. PMID 19517575 DOI: 10.1002/Pros.20980 |
0.605 |
|
2009 |
Bose SK, Gibson W, Bullard RS, Donald CD. PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin-1 in prostate cancer. Molecular Immunology. 46: 1140-8. PMID 19118900 DOI: 10.1016/J.Molimm.2008.11.004 |
0.748 |
|
2008 |
Bose SK, Bullard RS, Donald CD. Oncogenic role of engrailed-2 (en-2) in prostate cancer cell growth and survival. Translational Oncogenomics. 3: 37-43. PMID 21566742 |
0.748 |
|
2008 |
Cooper CR, Graves B, Pruitt F, Chaib H, Lynch JE, Cox AK, Sequeria L, van Golen KL, Evans A, Czymmek K, Bullard RS, Donald CD, Sol-Church K, Gendernalik JD, Weksler B, et al. Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha. Journal of Cellular Biochemistry. 104: 2298-309. PMID 18561328 DOI: 10.1002/Jcb.21785 |
0.684 |
|
2008 |
Bullard RS, Gibson W, Bose SK, Belgrave JK, Eaddy AC, Wright CJ, Hazen-Martin DJ, Lage JM, Keane TE, Ganz TA, Donald CD. Functional analysis of the host defense peptide Human Beta Defensin-1: new insight into its potential role in cancer. Molecular Immunology. 45: 839-48. PMID 17868871 DOI: 10.1016/J.Molimm.2006.11.026 |
0.748 |
|
2007 |
Gibson W, Green A, Bullard RS, Eaddy AC, Donald CD. Inhibition of PAX2 expression results in alternate cell death pathways in prostate cancer cells differing in p53 status. Cancer Letters. 248: 251-61. PMID 16996682 DOI: 10.1016/J.Canlet.2006.08.007 |
0.747 |
|
2005 |
Chen WW, Chan DC, Donald C, Lilly MB, Kraft AS. Pim family kinases enhance tumor growth of prostate cancer cells. Molecular Cancer Research : McR. 3: 443-51. PMID 16123140 DOI: 10.1158/1541-7786.Mcr-05-0007 |
0.556 |
|
2003 |
Donald CD, Sun CQ, Lim SD, Macoska J, Cohen C, Amin MB, Young AN, Ganz TA, Marshall FF, Petros JA. Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Laboratory Investigation; a Journal of Technical Methods and Pathology. 83: 501-5. PMID 12695553 |
0.476 |
|
Show low-probability matches. |